Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GH Guardant Health Inc.

盘后交易 11-05 16:26:45 EST

153.43

-15.15

-8.99%

盘后132.42

-21.01-13.69%

16:26 EST

最高165.10	最低151.92	成交量397.45万
今开165.00	昨收168.58	日振幅7.82%
总市值205.90亿	流通市值199.12亿	总股本1.34亿
成交额6.20亿	换手率3.06%	流通股本1.30亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GH","market":"US","secType":"STK","nameCN":"Guardant Health Inc.","latestPrice":153.43,"timestamp":1793912400000,"preClose":168.58,"halted":0,"volume":3974475,"hourTrading":{"tag":"盘后","latestPrice":132.42,"preClose":153.43,"latestTime":"16:26 EST","volume":133960,"amount":19264893.4284,"timestamp":1793914002866,"change":-21.01,"changeRate":-0.136935,"amplitude":0.223815},"delay":0,"changeRate":-0.08986831178075694,"floatShares":129778058,"shares":134196170,"eps":-3.503749,"marketStatus":"盘后交易","change":-15.15,"latestTime":"11-05 16:26:45 EST","open":165,"high":165.1,"low":151.9178,"amount":619580112.855,"amplitude":0.078196,"askPrice":135.65,"askSize":1300,"bidPrice":130.4,"bidSize":7,"shortable":3,"etf":0,"ttmEps":-3.503749,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1793926800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1538625600000,"exchange":"NASDAQ","adjPreClose":168.58,"preHourTrading":{"tag":"盘前","latestPrice":165.01,"preClose":168.58,"latestTime":"09:10 EST","volume":1657,"amount":276664.319,"timestamp":1793887855257,"change":-3.57,"changeRate":-0.021177,"amplitude":0.032329},"postHourTrading":{"tag":"盘后","latestPrice":132.42,"preClose":153.43,"latestTime":"16:26 EST","volume":133960,"amount":19264893.4284,"timestamp":1793914002866,"change":-21.01,"changeRate":-0.136935,"amplitude":0.223815},"volumeRatio":2.147131,"impliedVol":0.9708,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/GH","defaultTab":"news","newsList":[{"id":"1116958760","title":"异动解读｜Guardant Health Inc.盘后下跌7.12%，财报前后诉讼赔偿与持续提成压力压制情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1116958760","media":"行情直击","labels":[],"top":1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116958760?lang=zh_cn&edition=full","pubTime":"2026-11-06 05:07","pubTimestamp":1793912834,"startTime":"0","endTime":"0","summary":"11月6日，Guardant Health Inc.盘后下跌7.12%，报141.23美元，成交额1220.14万美元。消息面上，压制股价的核心仍是duplex sequencing相关专利诉讼风险。此前公司对涉案美国专利30项权利要求的挑战被驳回，维持故意侵权认定，相关赔偿、应计许可费及利息合计超过2.452亿美元。同时，法院要求公司自6月起至专利到期前，就涉案产品与服务支付6%销售提成。尽管市场此前看好Shield商业化及营收增长，但财报前后上述持续性法律与费用压力明显压制风险偏好。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health盘后下跌，专利赔偿与提成压力发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174933289","title":"异动解读｜Guardant Health Inc.盘中下跌5.36%，财报前专利诉讼赔偿与持续提成压力压制情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1174933289","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174933289?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:57","pubTimestamp":1793890625,"startTime":"0","endTime":"0","summary":"11月5日，Guardant Health Inc.盘中下跌5.36%，报160.4美元，成交额6119.36万美元。此次异动的核心压力来自专利诉讼进展对财报前风险偏好的压制。公司围绕duplex sequencing美国专利30项权利要求的挑战此前被驳回，维持故意侵权认定，相关赔偿、应计许可费及利息合计超过2.452亿美元；同时，自6月起至专利到期前，涉案产品与服务还需支付6%销售提成。Guardant Health, Inc.于2011年12月在特拉华州注册成立。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health盘中下跌，专利赔偿压力压制情绪","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113954675","title":"异动解读｜Guardant Health Inc.盘中下跌5.08%，财报前诉讼赔偿与专利风险压制情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1113954675","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113954675?lang=zh_cn&edition=full","pubTime":"2026-11-02 23:55","pubTimestamp":1793634914,"startTime":"0","endTime":"0","summary":"11月2日，Guardant Health Inc.盘中下跌5.08%，报169.82美元，成交额5528.66万美元。近期压制情绪的核心来自专利诉讼进展。公司对一项涉及duplex sequencing的美国专利30项权利要求提出的挑战被驳回，维持此前故意侵权认定，相关赔偿、应计许可费及利息合计超过2.452亿美元；法院还要求公司自6月起至专利到期前，就涉案产品与服务支付6%销售提成。这与市场此前围绕Shield商业化推进、检测覆盖扩张及机构偏多预期形成对冲，导致财报前风险偏好回落。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"专利败诉重罚，财报前股价跳水","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120798288","title":"异动解读｜Guardant Health Inc.盘中下跌5.26%，财报前诉讼赔偿与专利风险压制情绪","url":"https://stock-news.laohu8.com/highlight/detail?id=1120798288","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120798288?lang=zh_cn&edition=full","pubTime":"2026-10-31 02:39","pubTimestamp":1793385558,"startTime":"0","endTime":"0","summary":"10月31日，Guardant Health Inc.盘中下跌5.26%，报175.57美元，成交额1.35亿美元。近期可见的直接压制来自专利诉讼进展。公司对一项涉及duplex sequencing的美国专利30项权利要求提出的挑战被驳回，维持此前陪审团认定其故意侵权的结果，相关赔偿、应计许可费及利息合计超过2.452亿美元。法院还要求公司自6月起至相关专利到期前，就涉案产品与服务支付6%销售提成。这与市场原本聚焦的Shield商业化推进、检测覆盖扩张及11月初财报前的偏多预期形成对冲，短线情绪因而承压。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Guardant Health盘中下挫，专利赔偿与提成压制情绪","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161648673","title":"财报前瞻 | Guardant Health Inc.本季度营收预计增48.65%，机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1161648673","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161648673?lang=zh_cn&edition=full","pubTime":"2026-10-29 09:34","pubTimestamp":1793237651,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.将于2026年11月05日盘后发布财报，市场关注Shield商业化推进与利润修复节奏。公司当前的收入结构以“肿瘤学”为核心，上季度该项收入为2.19亿美元，占比65.41%，配合Guardant360、组织活检与MRD检测的协同带动订单与客单价改善。Redburn于2026年09月08日给予“买入”评级并覆盖，公司中长期增长逻辑在于多产品线的协同放量与支付覆盖面的稳步扩大。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | Guardant Health Inc.本季度营收预计增48.65%，机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128978918","title":"异动解读｜Guardant Health Inc.盘中上涨5.01%，专利挑战被驳回缓解诉讼压力","url":"https://stock-news.laohu8.com/highlight/detail?id=1128978918","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128978918?lang=zh_cn&edition=full","pubTime":"2026-10-22 02:35","pubTimestamp":1792607713,"startTime":"0","endTime":"0","summary":"10月22日，Guardant Health Inc.盘中上涨5.01%，报170.73美元/股，成交额1.74亿美元。推动股价异动的公开消息是，公司针对双重测序相关美国专利提出的全部30项权利要求挑战被专利审判与上诉委员会驳回。该裁决维持了此前故意侵权认定对应的法律基础。相关案件中，公司此前已被判支付超过2.452亿美元赔偿、应计特许权使用费及利息，并自6月起至专利于3月到期前，对涉案11项产品和服务销售额支付6%特许权使用费。最新结果意味着公司试图推翻关键专利有效性的努力未获支持。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"专利挑战被驳回，Guardant Health盘中上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164269432","title":"异动解读｜Guardant Health盘中下跌5.16%，专利诉讼败诉赔偿压力持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1164269432","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164269432?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:15","pubTimestamp":1791825314,"startTime":"0","endTime":"0","summary":"10月13日，Guardant Health盘中下跌5.16%，报158.825美元/股，成交额1.07亿美元。消息面上，公司此前在TwinStrand Biosciences及华盛顿大学提起的专利侵权诉讼中败诉，被判赔逾2.452亿美元，并须就11项产品及服务支付6%特许权使用费，市场持续消化该判决带来的财务与合规压力。Guardant Health是一家领先的精密肿瘤学公司，致力于通过专有血液测试、大量数据集和高级分析帮助全球征服癌症，其检测覆盖早期癌症筛查、复发监测及晚期治疗方案选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health股价下挫，专利败诉赔偿压力发酵","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191822290","title":"异动解读｜Guardant Health盘中下跌5.36%，阿斯利康试验失败利好效应遭获利回吐","url":"https://stock-news.laohu8.com/highlight/detail?id=1191822290","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191822290?lang=zh_cn&edition=full","pubTime":"2026-10-06 22:13","pubTimestamp":1791295989,"startTime":"0","endTime":"0","summary":"10月6日，Guardant Health盘中下跌5.36%，报177.2美元/股，成交额1.18亿美元。此前一个交易日该股上涨5.30%，创52周新高187.69美元。消息面上，瑞银最新报告指出阿斯利康Serena-4试验失败验证了液体活检技术路线，公司作为该领域领导者直接受益，瑞银将目标价从175美元上调至225美元并维持买入评级。此外，公司结直肠癌检测项目被纳入Evicore承保范围，叠加乳腺癌伴随诊断试剂获批FDA，多项利好共振推动股价连续上攻后出现技术性回调。Guardant Health是一家精密肿瘤学公司，通过血液检测和大数据分析提供癌症筛查、复发监测及治疗方案选择服务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health回落，液体活检利好遭获利回吐","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100226523","title":"异动解读｜Guardant Health盘中上涨5.07%，UBS称公司受益靶向疗法机制验证","url":"https://stock-news.laohu8.com/highlight/detail?id=1100226523","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100226523?lang=zh_cn&edition=full","pubTime":"2026-10-06 03:03","pubTimestamp":1791226990,"startTime":"0","endTime":"0","summary":"10月6日，Guardant Health盘中上涨5.07%，报186.81美元/股，成交额1.61亿美元。消息面上，瑞银最新报告指出阿斯利康Serena-4试验失败验证了液体活检技术路线，公司作为该领域领导者直接受益。此前公司结直肠癌检测项目被纳入Evicore承保范围，叠加乳腺癌伴随诊断试剂获批FDA引发价值重估。公司是一家精密肿瘤学公司，通过血液检测和大数据分析提供癌症筛查、复发监测及治疗方案选择服务。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194793262","title":"异动解读｜Guardant Health盘中上涨5.31%，Shield血液检测再获重磅保险覆盖协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1194793262","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194793262?lang=zh_cn&edition=full","pubTime":"2026-09-16 00:37","pubTimestamp":1789490240,"startTime":"0","endTime":"0","summary":"9月15日，Guardant Health盘中上涨5.31%，报176.75美元/股，成交额1.89亿美元。消息面上，公司宣布Evernorth旗下Evicore已将其Shield血液检测纳入结直肠癌筛查承保范围，覆盖自明年1月1日起正式生效。此前公司已与Carelon达成类似协议，商业保险覆盖人群已扩展至约9000万人，占美国符合条件患者的75%。此次新增Evicore覆盖，进一步打开Shield的商业化空间。Guardant Health是一家精密肿瘤学公司，利用血液检测、真实世界数据及人工智能分析，为癌症筛查、复发监测及治疗方案选择提供关键见解。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health大涨，Shield检测获重磅保险覆盖","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103100254","title":"Guardant Health与Evernorth旗下Evicore达成协议，Shield血液检测自2027年1月1日起纳入结直肠癌筛查覆盖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1103100254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1103100254?lang=zh_cn&edition=full","pubTime":"2026-09-15 04:08","pubTimestamp":1789416490,"startTime":"0","endTime":"0","summary":"Guardant Health公司宣布，Evernorth旗下的Evicore已决定将其Shield血液检测纳入结直肠癌（CRC）筛查的承保范围。这项覆盖计划将于2027年1月1日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","HELX","LU0320765992.SGD","BK4588","GNOM","GDOC","EKG","LU0109394709.USD","BK4551","LU0889565916.HKD","GNMX","GH","FFOX","BK4585","LFSC","PTH","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116354483","title":"Guardant Health重磅里程碑：Guardant360® Cdx获FDA批准，成为阿斯利康Ectamah™（Camizestrant）晚期乳腺癌伴随诊断","url":"https://stock-news.laohu8.com/highlight/detail?id=1116354483","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116354483?lang=zh_cn&edition=full","pubTime":"2026-09-05 06:11","pubTimestamp":1788559873,"startTime":"0","endTime":"0","summary":"Guardant Health今日宣布，其Guardant360 Cdx液体活检产品已获得美国食品药品监督管理局的里程碑式批准，正式成为阿斯利康新型内分泌疗法Ectamah在晚期乳腺癌治疗中的伴随诊断工具。Guardant Health管理层在声明中表示，这一里程碑不仅是对公司技术实力的权威认可，更是对癌症患者个体化治疗承诺的有力践行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0109394709.USD","GNOM","BK4196","GH","BK4551","FFOX","LU0320765992.SGD","LU0889565916.HKD","BK4535","BK4588","GNMX","HELX","PTH","GDOC","EKG","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160211496","title":"Twinstrand：法院判决公司及Uw获赔逾2.452亿美元，涵盖截至2026年5月31日的侵权损害赔偿、应计特许权使用费及利息","url":"https://stock-news.laohu8.com/highlight/detail?id=1160211496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160211496?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:01","pubTimestamp":1787569302,"startTime":"0","endTime":"0","summary":"Twinstrand公告，法院已作出裁决，判令公司及Uw获得超过2.452亿美元的赔偿金。这笔款项涵盖了截至2026年5月31日期间所发生的侵权损害、累积的特许权使用费以及相应利息。\n裁决金额之巨，彰显了司法体系对知识产权保护的坚定立场。赔偿总额精确计算至该截止日期，包括了多层次的补偿要素。侵权行为的认定范围，则明确划定在2026年5月31日之前发生的全部相关行为。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","LU0320765992.SGD","GNMX","BK4585","BK4588","GDOC","BK4551","LU0889565916.HKD","EKG","PTH","BK4196","BK4535","GNOM","GH","HELX","LU0109394709.USD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194764905","title":"Twinstrand胜诉：法院维持2023年故意侵权判决，并裁定Guardant Health 11项产品与服务须支付6%特许权使用费","url":"https://stock-news.laohu8.com/highlight/detail?id=1194764905","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194764905?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:01","pubTimestamp":1787569276,"startTime":"0","endTime":"0","summary":"法院裁定，维持2023年关于故意侵权的判决，同时要求Guardant Health公司就其11项产品及服务所产生的销售额，向Twinstrand支付6%的特许权使用费。这一裁决意味着，Twinstrand在知识产权纠纷中取得了关键性胜利。对于Guardant Health而言，这项决定无疑构成了财务上的重大负担。Twinstrand方面则对这一结果表示认可。此次6%特许权使用费的设定，亦反映了法院对此类行为的态度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","GH","BK4196","EKG","GDOC","BK4551","GNMX","HELX","LFSC","LU0320765992.SGD","PTH","FFOX","LU0109394709.USD","BK4588","GNOM","BK4585","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127912643","title":"Twinstrand案判决：Guardant Health须按季度向公司及承销商汇报11款产品与服务的全美销售明细","url":"https://stock-news.laohu8.com/highlight/detail?id=1127912643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127912643?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"根据Twinstrand方面的消息，法院判决要求Guardant Health必须履行一项新的义务——按季度提交其在美国市场上全部11款产品与服务的销售账目，以供公司与承销商查阅。\n这一判决意味着，Guardant Health在运营透明度和合规性上将面临更为严格的监督。具体而言，公司需定期整理并呈报相关销售数据，确保各方能够及时掌握其业务动态。\n此举无疑为市场参与者提供了更清晰的视角，去审视这家精准医疗领域领军企业的真实业绩表现。季度汇报机制的建立，或将进一步影响投资者对该公司未来走势的评估与判断。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","LU0109394709.USD","BK4551","GNMX","LU0320765992.SGD","GH","GDOC","BK4196","GNOM","LFSC","BK4535","BK4588","FFOX","BK4585","LU0889565916.HKD","HELX","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136746995","title":"Twinstrand：特拉华州法院于8月21日裁定公司及华盛顿大学在针对Guardant Health的专利侵权诉讼中胜诉","url":"https://stock-news.laohu8.com/highlight/detail?id=1136746995","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136746995?lang=zh_cn&edition=full","pubTime":"2026-08-24 19:00","pubTimestamp":1787569211,"startTime":"0","endTime":"0","summary":"Twinstrand宣布，特拉华州法院已于8月21日作出判决，支持公司及华盛顿大学的立场，认定其在针对Guardant Health提起的专利侵权诉讼中占据优势。这一裁决标志着这场备受关注的法律纠纷取得了阶段性胜利。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNMX","GH","HELX","LFSC","BK4535","BK4588","BK4585","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","BK4551","GDOC","FFOX","PTH","BK4196","GNOM","EKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151455938","title":"异动解读｜Guardant Health盘中上涨5.03%，报171.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1151455938","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151455938?lang=zh_cn&edition=full","pubTime":"2026-08-21 02:17","pubTimestamp":1787249823,"startTime":"0","endTime":"0","summary":"8月21日，Guardant Health盘中上涨5.03%，报171.55美元/股，成交额2.07亿美元。Guardant Health所在的保健护理服务行业中，个股表现分化，其中Hims & Hers Health Inc.涨2.9%，西维斯健康涨0.52%，奎斯特诊疗涨0.23%，徕博科涨0.89%，信诺保险跌0.73%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122159182","title":"异动解读｜Guardant Health盘中上涨5.39%，Q2营收大超预期叠加全年指引上调延续强势","url":"https://stock-news.laohu8.com/highlight/detail?id=1122159182","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122159182?lang=zh_cn&edition=full","pubTime":"2026-08-07 21:56","pubTimestamp":1786111001,"startTime":"0","endTime":"0","summary":"8月7日，Guardant Health盘中上涨5.39%，报166.35美元/股，成交额4265.67万美元，延续财报发布后的上行势头。消息面上，公司此前公布的Q2财报显示营收3.35亿美元，同比增长44.3%，大幅超出市场预期的3.14亿美元；同时将全年营收指引从13.0亿-13.2亿美元上调至13.4亿-13.6亿美元，显著高于分析师预期的13.1亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health盘中上涨5.39%，Q2营收大超预期叠加全年指引上调延续强势","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183698521","title":"异动解读｜Guardant Health夜盘上涨5.67%，Q2营收大超预期且上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1183698521","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1183698521?lang=zh_cn&edition=full","pubTime":"2026-07-31 11:38","pubTimestamp":1785469114,"startTime":"0","endTime":"0","summary":"7月31日，Guardant Health夜盘上涨5.67%，报160.99美元/股。消息面上，公司盘后发布第二季度财报，营收达3.35亿美元，同比增长44.3%，显著超出市场预期的3.14亿美元；调整后每股亏损0.42美元，同比收窄。此外，近期公司获得多项积极进展，包括Guardant360 Liquid CDx获FDA批准为多癌种伴随诊断、Shield血检被纳入美国癌症学会结直肠癌筛查指南，以及多家机构上调目标价，共同提振市场情绪。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Guardant Health夜盘上涨5.67%，Q2营收大超预期且上调全年指引","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171842386","title":"异动解读 | 夜盘大涨5.67%，Guardant Health Q2财报超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1171842386","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171842386?lang=zh_cn&edition=full","pubTime":"2026-07-31 11:28","pubTimestamp":1785468536,"startTime":"0","endTime":"0","summary":"Guardant Health Inc.今日夜盘股价大涨5.67%，引起了市场的广泛关注。消息面上，公司于盘后发布了第二季度财报，营收达3.35亿美元，同比增长44.3%，显著超出市场预期的3.14亿美元；调整后每股亏损0.42美元，同比大幅收窄。强劲的业绩表现和乐观的指引是推动夜盘股价大涨的核心原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GH"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.guardanthealth.com","stockEarnings":[{"period":"1week","weight":-0.0767},{"period":"1month","weight":-0.0996},{"period":"3month","weight":0.0698},{"period":"6month","weight":0.7615},{"period":"1year","weight":0.7178},{"period":"ytd","weight":0.6505}],"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Guardant Health, Inc.于2011年12月在特拉华州注册成立。该公司是一家领先的精密肿瘤学公司，致力于通过使用其专有血液测试，大量数据集和高级分析来帮助全球征服癌症。他们利用先进的血液和组织检测、真实世界数据和人工智能分析，提供关于疾病驱动因素的关键见解，从而变革患者护理。他们的检测有助于改善各个阶段的治疗效果，包括早期癌症筛查、早期癌症复发监测以及晚期癌症患者的治疗方案选择。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.071093},{"month":2,"riseRate":0.25,"avgChangeRate":0.034152},{"month":3,"riseRate":0.5,"avgChangeRate":-0.022808},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022604},{"month":5,"riseRate":0.625,"avgChangeRate":0.118443},{"month":6,"riseRate":0.75,"avgChangeRate":0.091261},{"month":7,"riseRate":0.75,"avgChangeRate":0.055},{"month":8,"riseRate":0.5,"avgChangeRate":0.070736},{"month":9,"riseRate":0.375,"avgChangeRate":-0.042394},{"month":10,"riseRate":0.375,"avgChangeRate":0.026879},{"month":11,"riseRate":0.666667,"avgChangeRate":0.109584},{"month":12,"riseRate":0.5,"avgChangeRate":-0.066498}],"exchange":"NASDAQ","name":"Guardant Health Inc.","nameEN":"Guardant Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Guardant Health Inc.,GH,Guardant Health Inc.股票,Guardant Health Inc.股票老虎,Guardant Health Inc.股票老虎国际,Guardant Health Inc.行情,Guardant Health Inc.股票行情,Guardant Health Inc.股价,Guardant Health Inc.股市,Guardant Health Inc.股票价格,Guardant Health Inc.股票交易,Guardant Health Inc.股票购买,Guardant Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Guardant Health Inc.(GH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Guardant Health Inc.(GH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}